Target intelligence / Profile preview

Endoplasmic reticulum stress-induced apoptotic pathway

Molecular classification
Other (signaling pathway; includes components that are transcription factors, kinases, caspases, and chaperones, e.g., PERK, ATF6, IRE1, CHOP/GADD153, Caspase 12/4, JNK, BCL2 family)
01

Overview

The endoplasmic reticulum stress-induced apoptotic pathway is a conserved cellular mechanism activated in response to prolonged or unresolvable ER stress, typically triggered by misfolded protein accumulation, calcium dysregulation, oxidative stress, or energy imbalance[1][2][3]. The unfolded protein response (UPR) initially aims to restore homeostasis by halting protein translation, increasing chaperone expression, and enhancing degradation of misfolded proteins (ERAD). If stress persists, signaling switches to pro-apoptotic outputs through molecules such as CHOP/GADD153 (inducing pro-apoptotic genes and downregulating anti-apoptotic BCL2 family members), JNK (facilitating mitochondrial apoptosis), and caspases (execution phase)[1][2][3][4]. This switch is central to pathophysiology in many diseases marked by chronic cell stress, such as neurodegeneration, metabolic disorders, and cancer.

Other names
ER stress-induced apoptosisER stress apoptotic pathwayunfolded protein response-mediated apoptosis
02

Mechanism of action

Inhibition or activation of UPR sensors (PERK, IRE1, ATF6), modulation of downstream effectors (CHOP, JNK, caspases), use of chemical chaperones to alleviate protein misfolding, antioxidants to reduce ER-induced oxidative stress, direct proteostasis modulation

03

Biological functions

Apoptosisprotein quality controlunfolded protein responsecell deathoxidative stress responsecell survival decision-making
04

Disease associations

Neurodegenerative diseasecancerdiabetesatherosclerosiscardiovascular diseaserenal diseaseother conditions with chronic cell stress
05

Safety considerations

Global inhibition or modulation of the pathway can affect essential cellular stress responses, risking widespread toxicity, immune modulation, or off-target cell deathtargeting downstream effectors may have more selectivity but remains challenging
06

Interacting drugs

No drugs directly target the pathway as a whole, but several drugs modulate key components (e.g., PERK inhibitors, IRE1 inhibitors, chemical chaperones, antioxidants like butylated hydroxyanisole (BHA), proteasome inhibitors like bortezomib, thapsigargin as an ER stress inducer)
07

Biomarkers

CHOP (GADD153) expressionGRP78/BiPphosphorylated eIF2αspliced XBP1caspase 4/12 activityATF6 cleavage productJNK activationmitochondrial cytochrome c release

Beyond the preview

Go deeper on Endoplasmic reticulum stress-induced apoptotic pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum stress-induced apoptotic pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call